Jason Gross - Net Worth and Insider Trading
Jason Gross Net Worth
The estimated net worth of Jason Gross is at least $171,616 dollars as of 2024-11-13. Jason Gross is the Senior Officer of HLS Therapeutics Inc and owns about 49,600 shares of HLS Therapeutics Inc (TSX:HLS) stock worth over $171,616. Details can be seen in Jason Gross's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jason Gross has not made any transactions after 2019-12-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jason Gross
Jason Gross Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jason Gross owns 1 companies in total, including HLS Therapeutics Inc (TSX:HLS) .
Click here to see the complete history of Jason Gross’s form 4 insider trades.
Insider Ownership Summary of Jason Gross
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:HLS | HLS Therapeutics Inc | 2019-12-05 | Senior Officer |
Jason Gross Latest Holdings Summary
Jason Gross currently owns a total of 1 stock. Jason Gross owns 49,600 shares of HLS Therapeutics Inc (TSX:HLS) as of December 5, 2019, with a value of $171,616.
Latest Holdings of Jason Gross
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:HLS | HLS Therapeutics Inc | 2019-12-05 | 49,600 | 3.46 | 171,616 |
Holding Weightings of Jason Gross
Jason Gross Form 4 Trading Tracker
According to the SEC Form 4 filings, Jason Gross has made a total of 2 transactions in HLS Therapeutics Inc (TSX:HLS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in HLS Therapeutics Inc is the acquisition of 100 shares on December 5, 2019, which cost Jason Gross around $1,761.
Insider Trading History of Jason Gross
- 1
Jason Gross Trading Performance
GuruFocus tracks the stock performance after each of Jason Gross's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jason Gross is 24.83%. GuruFocus also compares Jason Gross's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jason Gross within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jason Gross's insider trading performs compared to the benchmark.
Performance of Jason Gross
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 41.26 | | | | | |
| Relative Return to S&P 500(%) | 37.49 | | | | | |
Jason Gross Ownership Network
Ownership Network List of Jason Gross
Ownership Network Relation of Jason Gross
Jason Gross Owned Company Details
What does HLS Therapeutics Inc do?
Who are the key executives at HLS Therapeutics Inc?
Jason Gross is the Senior Officer of HLS Therapeutics Inc. Other key executives at HLS Therapeutics Inc include Director & Senior Officer Craig Millian , Senior Officer Brian Thomas Walsh , and 10% Security Holder Polar Asset Management Partners Inc. .
HLS Therapeutics Inc (TSX:HLS) Insider Trades Summary
Over the past 18 months, Jason Gross made no insider transaction in HLS Therapeutics Inc (TSX:HLS). Other recent insider transactions involving HLS Therapeutics Inc (TSX:HLS) include a net purchase of 20,000 shares made by Tim Hendrickson , a net purchase of 12,500 shares made by Craig Millian , and a net purchase of 32,400 shares made by Polar Asset Management Partners Inc. .
In summary, during the past 3 months, insiders sold 0 shares of HLS Therapeutics Inc (TSX:HLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,300,000 shares of HLS Therapeutics Inc (TSX:HLS) were sold and 167,100 shares were bought by its insiders, resulting in a net sale of 1,132,900 shares.
HLS Therapeutics Inc (TSX:HLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
HLS Therapeutics Inc Insider Transactions
Jason Gross Mailing Address
Above is the net worth, insider trading, and ownership report for Jason Gross. Currently GuruFocus does not have mailing address information for Jason Gross.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
